Finzati - Logo
INVA logo

Innoviva, Inc.

INVA • Biotechnology
$21.33
▼ -0.02 (-0.09%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.57B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 63.8%Positive revenue growth · 7.2%Positive free cash flow · 2.91Consistent free cash flow · 5/5Reasonable earnings multiple · 4.97
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$21.33
Change-0.09%
Shares Out73.42M
Market Cap$1.57B
Enterprise Value$1.25B
52W Range16.52 - 25.15
Beta0.34
P/E4.38
P/S3.53
P/B1.27
P/FCF7.02
EV/Sales2.81

Investment DNA

How strong this company looks for long-term investors

82
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
93/100
Growth Potential
Revenue and expansion
51/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Stable or improving margins · 63.8%Positive revenue growth · 7.2%Positive free cash flow · 2.91Consistent free cash flow · 5/5Reasonable earnings multiple · 4.97Manageable debt level · 0.23

Analyst view

Analyst sentiment and price target

INVA
Analyst sentiment
Based on 10 analyst votes · 2026-09-04
70/100
Bullish
Bullish
5
Hold
4
Bearish
1
Price Target
2026-08-07
Low
$32.00
Mean
$37.00
Median
$37.00
High
$42.00

Company Overview

IPO: 10/5/2004
Industry: Biotechnology
P/B i: 1.27
Debt / Equity i: 0.23
Operating Margin: 38.52%
Net Margin: 63.78%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.23
Current Ratio: 14.64
Quick Ratio: 13.85
Status: Strong

Insider Transactions

Recent executive and insider activity

Zhen Marianne
Transaction: 05/20/2026
SELL
Change
-1,127
Price
$22.24
Filing
05/22/2026
Type
SELL
Raifeld Pavel
Transaction: 05/20/2026
SELL
Change
-1,130
Price
$22.24
Filing
05/22/2026
Type
SELL
Basso Stephen
Transaction: 05/20/2026
SELL
Change
-559
Price
$22.24
Filing
05/22/2026
Type
SELL